GABAergic Neurons in Neurodegeneration

📖 Wiki Page

cell1858 wordssynced 2026-04-02

GABAergic Neurons in Neurodegeneration

Overview

...

GABAergic Neurons in Neurodegeneration

Overview

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">GABAergic Neurons in Neurodegeneration</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000617](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000617)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000617](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000617)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4300028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4300028)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Target</td>
</tr>
<tr>
<td class="label">PV basket cells</td>
<td>Pyramidal soma</td>
</tr>
<tr>
<td class="label">CCK basket cells</td>
<td>Pyramidal soma</td>
</tr>
<tr>
<td class="label">Axo-axonic cells</td>
<td>Axon initial segment</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Target</td>
</tr>
<tr>
<td class="label">SST interneurons</td>
<td>Dendrites</td>
</tr>
<tr>
<td class="label">VIP interneurons</td>
<td>Dendrites</td>
</tr>
<tr>
<td class="label">Neurogliaform cells</td>
<td>Distal dendrites</td>
</tr>
<tr>
<td class="label">Subunit</td>
<td>Location</td>
</tr>
<tr>
<td class="label">α1</td>
<td>Widely distributed</td>
</tr>
<tr>
<td class="label">α2</td>
<td>Anxiety, motor</td>
</tr>
<tr>
<td class="label">α3</td>
<td>Sparse</td>
</tr>
<tr>
<td class="label">α5</td>
<td>Hippocampus</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Target</td>
</tr>
<tr>
<td class="label">GABA-A modulators</td>
<td>Cl- channel</td>
</tr>
<tr>
<td class="label">GABA-B agonists</td>
<td>GPCR</td>
</tr>
<tr>
<td class="label">Neurosteroids</td>
<td>Allosteric sites</td>
</tr>
<tr>
<td class="label">Drug Class</td>
<td>Example</td>
</tr>
<tr>
<td class="label">Benzodiazepines</td>
<td>Diazepam</td>
</tr>
<tr>
<td class="label">Barbiturates</td>
<td>Phenobarbital</td>
</tr>
<tr>
<td class="label">Neurosteroids</td>
<td>Allopregnanolone</td>
</tr>
<tr>
<td class="label">Oscillation Type</td>
<td>Frequency</td>
</tr>
<tr>
<td class="label">Gamma</td>
<td>30-100 Hz</td>
</tr>
<tr>
<td class="label">Beta</td>
<td>13-30 Hz</td>
</tr>
<tr>
<td class="label">Theta</td>
<td>4-8 Hz</td>
</tr>
<tr>
<td class="label">Ripple</td>
<td>150-200 Hz</td>
</tr>
<tr>
<td class="label">Receptor</td>
<td>Change</td>
</tr>
<tr>
<td class="label">GABA-A α1</td>
<td>Downregulated</td>
</tr>
<tr>
<td class="label">GABA-A α5</td>
<td>Altered</td>
</tr>
<tr>
<td class="label">GABA-B</td>
<td>Reduced</td>
</tr>
<tr>
<td class="label">KCC2</td>
<td>Downregulated</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">GABA-A α1</td>
<td>Positive allosteric modulators</td>
</tr>
<tr>
<td class="label">GABA-A α5</td>
<td>Selective modulators</td>
</tr>
<tr>
<td class="label">GABA-B</td>
<td>Baclofen derivatives</td>
</tr>
<tr>
<td class="label">KCC2</td>
<td>Enhancers</td>
</tr>
</table>

Gabaergic Neurons In Neurodegeneration plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

Morphology: GABAergic neuron (source: Cell Ontology)
Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

Unknown (PanglaoDB):

External Database Links

[Cell Ontology (CL:0000617)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000617)
[OBO Foundry (CL:0000617)](http://purl.obolibrary.org/obo/CL_0000617)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)
[PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

Unknown (PanglaoDB):

External Database Links

[Cell Ontology (CL:0000617)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000617)
[OBO Foundry (CL:0000617)](http://purl.obolibrary.org/obo/CL_0000617)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[PanglaoDB](https://panglaodb.se/)

Introduction

GABAergic neurons are inhibitory neurons that utilize gamma-aminobutyric acid (GABA) as their primary neurotransmitter. They play crucial roles in maintaining neural circuit balance, preventing hyperexcitability, and coordinating information processing throughout the brain. Dysfunction of GABAergic neurons contributes significantly to hyperexcitability, seizures, and network dysfunction observed in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington's disease, and Amyotrophic Lateral Sclerosis[@palop2010].

Classification of GABAergic Neurons

Cortical and Hippocampal Interneurons

GABAergic interneurons in the cortex and hippocampus are remarkably diverse[@freund2007]:

Perisomatic Inhibitors

Dendritic Inhibitors

Other Interneurons

CCK-expressing interneurons: Diverse functions
Ivy cells: NPY co-expression
Mystery cells: Emerging populations

Subcortical GABAergic Populations

Basal Ganglia

Striatal medium spiny neurons (MSNs): Primary output neurons
Fast-spiking interneurons: Local inhibition
Globus pallidus neurons: Inhibitory output
Substantia nigra pars reticulata: Motor inhibition

Thalamus

Thalamic reticular nucleus (TRN): Gating and attention
Thalamic interneurons: Local processing

Other Regions

Cerebellar interneurons: Purkinje cell modulation
Brainstem nuclei: Autonomic control
Hypothalamic populations: Homeostatic regulation

Molecular Mechanisms

GABA Synthesis and Release

GABAergic neurotransmission depends on specific machinery[@benarroch2007]:

GAD67 (GAD1): Primary synthesizing enzyme
GAD65 (GAD2): Synaptic vesicle localization
VGAT (VIAAT): Vesicular transporter
GABA transporters (GATs): Reuptake

Receptor Subtypes

GABA-A Receptors

Ligand-gated chloride channels with multiple subunits:

GABA-B Receptors

Metabotropic receptors:

G-protein coupled (Gi/o)
Pre-synaptic: Ca2+ inhibition
Post-synaptic: K+ channel activation

Dysfunction in Neurodegenerative Diseases

Alzheimer's Disease

GABAergic dysfunction in AD is extensive[@zhou2022]:

Changes Observed

PV neuron loss: Specific vulnerability in hippocampus
SST neuron alterations: Early changes
Network hyperexcitability: Seizure susceptibility
GABA levels: Often reduced in CSF

Mechanisms

Amyloid-beta effects:

Direct toxicity to interneurons
Receptor dysfunction
Synaptic impairment

Tau pathology:

Neuronal loss
Circuit disconnection

Network dysfunction:

Oscillation disruption
Memory circuit impairment
Hyperexcitability

Therapeutic Implications

Parkinson's Disease

GABAergic changes in PD are central to motor dysfunction[@albin2002]:

Basal Ganglia Alterations

Striatal MSNs: Firing rate changes
GPe hyperactivity: Increased inhibition
GPi/SNr output: Excessive inhibition
STN activity: Disrupted

Motor Symptoms

Bradykinesia
Rigidity
Tremor (less prominent)

Treatment Effects

L-DOPA: Modifies GABAergic activity
DBS: Normalizes pathological patterns
Dyskinesias: GABAergic involvement

Huntington's Disease

GABAergic loss is early and progressive[@albin2020]:

Striatal Vulnerability

MSNs early loss: Most vulnerable
Interneuron preservation: Relative
Indirect pathway: Particularly affected

Pathophysiology

Loss of inhibition
Hyperexcitability
Network breakdown
Hyperkinetic movements

Amyotrophic Lateral Sclerosis

Cortical hyperexcitability features prominently[@turner2018]:

Cortical GABAergic dysfunction: Early
Inhibitory neuron loss: Variable
Receptor changes: Altered subunit composition
Excitability: Increased

Therapeutic Approaches

Pharmacological Modulation

GABA-A Targeting Drugs

GABA-B Targeting

Baclofen: Spasticity, being explored for ALS
CGP-55845: Research tool
Arbaclofen: Clinical trials

Novel Approaches

GABA-A α5-selective modulators: Cognitive effects
Targeted delivery: Region-specific
Gene therapy: GAD delivery

Emerging Strategies

Cell-Based Therapy

GABAergic progenitor transplantation: Preclinical
iPSC-derived neurons: Patient-specific
Direct conversion: Glia to neurons

Gene Therapy

GAD1/GAD2 delivery: Increase GABA synthesis
Receptor modification: Enhance sensitivity
Channel engineering: Circuit-specific

Biomarkers

CSF GABA: Biomarker potential
MRS imaging: Cortical GABA levels
PET ligands: Receptor imaging

Circuit Dysfunction in Neurodegeneration

Network Hyperexcitability Mechanisms

The loss of GABAergic inhibition leads to network hyperexcitability through several interconnected mechanisms[@palop2010][@li2021]:

Mermaid diagram (expand to render)

Oscillation Disruption

GABAergic interneurons are critical for generating brain oscillations:

The disruption of these oscillations contributes to cognitive decline in neurodegenerative diseases[@klausberger2003][@hu2014].

Specific Vulnerabilities

Parvalbumin (PV) Neurons

PV-expressing interneurons are particularly vulnerable in several conditions[@kelley2018][@murray2018]:

Alzheimer's Disease: Early loss of PV neurons in hippocampus contributes to memory impairment

Temporal Lobe Epilepsy: PV neuron dysfunction is both cause and consequence of seizures

Tauopathies: Pathogenic tau accumulates in PV neurons, impairing their function

Somatostatin (SST) Neurons

SST neurons show early dysfunction in AD:

Target dendritic shafts of pyramidal neurons
Regulate input integration
Vulnerable to amyloid toxicity
Changes precede PV neuron loss

Molecular Mechanisms of Vulnerability

Intrinsic Mechanisms

GABAergic neurons exhibit specific vulnerabilities[@marin2012][@gondora2019]:

Metabolic Sensitivity: High energy demands make them vulnerable to mitochondrial dysfunction

Calcium Dysregulation: Fast-spiking neurons have high calcium influx

Oxidative Stress: Lower antioxidant capacity in some interneuron subtypes

Proteostasis Failure: Impaired protein quality control mechanisms

Synaptic Mechanisms

Mermaid diagram (expand to render)

Receptor Alterations

Specific receptor changes in GABAergic neurons[@whitt2018][@devore2020]:

Basal Ganglia Dysfunction in Movement Disorders

Parkinson's Disease

GABAergic changes in PD are central to motor dysfunction[@pal2019][@espay2014]:

Mermaid diagram (expand to render)

Treatment Implications:

L-DOPA modifies GABAergic activity but causes dyskinesias
Deep brain stimulation (DBS) normalizes pathological patterns
GABAergic drugs may help manage motor symptoms

Huntington's Disease

GABAergic loss is early and progressive[@burkhardt2008][@gruber2019]:

Striatal MSN Vulnerability: Most susceptible to degeneration

Interneuron Preservation: Relative sparing of some subtypes

Indirect Pathway: Particularly affected

Dystonia: GABAergic contribution to motor symptoms

Therapeutic Targeting

Amyotrophic Lateral Sclerosis

Cortical Hyperexcitability

ALS features prominent cortical hyperexcitability[@turner2018][@fischer2020]:

GABAergic Dysfunction: Early and progressive

Receptor Changes: Altered subunit composition

Inhibitory Neuron Loss: Variable across subtypes

Excitability Increase: Cortical hyperexcitability precedes symptoms

Therapeutic Strategies[@menichetti2019]

GABA-A modulators: Restore inhibition
GABA-B agonists: Enhance presynaptic inhibition
Cell therapy: GABAergic progenitor transplantation
Gene therapy: GAD delivery to increase GABA synthesis

Biomarkers and Diagnostics

Current Approaches

CSF GABA: Marker of GABAergic function
MRS Imaging: Non-invasive cortical GABA measurement
PET Ligands: GABA receptor imaging
EEG: Network dysfunction quantification

Emerging Biomarkers

Interneuron-specific protein markers
Gene expression signatures
Single-cell electrophysiology patterns

Research Directions

Unresolved Questions

Cell-Type Specificity: Which specific interneuron subtypes are most vulnerable?

Temporal Sequence: What triggers early interneuron dysfunction?

Therapeutic Targeting: How can we selectively modulate specific interneuron types?

Future Directions

Single-cell transcriptomics to identify novel targets
Optogenetic approaches for cell-type specific manipulation
Translational studies in patient-derived models
Biomarker development for early detection

Key Publications

[Palop JJ, Mucke L. Epilepsy and hyperexcitability in Alzheimer's disease. Nat Rev Neurosci. 2010](https://doi.org/10.1038/nrn2930)

[Freund TF, Katona I. Perisomatic inhibition in neuronal networks. Neuron. 2007](https://doi.org/10.1016/j.neuron.2007.09.012)

[Benarroch EE. GABA receptor heterogeneity, function, and implications for CNS disorders. Neurology. 2007](https://pubmed.ncbi.nlm.nih.gov/17341125/)

[Zhou X et al. GABAergic dysfunction in Alzheimer's disease. J Alzheimers Dis. 2022](https://pubmed.ncbi.nlm.nih.gov/35094653/)

[Albin RL et al. Preclinical evidence for early GABAergic dysfunction in Huntington's disease. Brain. 2020](https://pubmed.ncbi.nlm.nih.gov/32519644/)

[Turner MR et al. Cortical hyperexcitability in amyotrophic lateral sclerosis. Lancet Neurol. 2018](https://pubmed.ncbi.nlm.nih.gov/29903345/)

[Li M et al. GABAergic system breakdown in Alzheimer's disease. Ageing Res Rev. 2021](https://pubmed.ncbi.nlm.nih.gov/34090854/)

[Pal A et al. GABAergic signaling in Parkinson's disease. Neuropharmacology. 2019](https://pubmed.ncbi.nlm.nih.gov/30471261/)

[Menichetti L et al. Targeting GABAergic dysfunction in ALS. J Neurol. 2019](https://pubmed.ncbi.nlm.nih.gov/30868456/)

[Fischer K et al. Early GABAergic deficits in ALS. Ann Neurol. 2020](https://pubmed.ncbi.nlm.nih.gov/32478912/)

External Links

[GABA and Inhibitory Neurons - Allen Brain Atlas](https://mouse.brain-map.org/)
[GABA Receptor Structure - PDB](https://www.rcsb.org/)
[Neurodegeneration Research - NIH](https://www.ninds.nih.gov/)
[Interneuron Diversity - Neuron](https://www.sciencedirect.com/journal/neuron)

Pathway Diagram

The following diagram shows the key molecular relationships involving GABAergic Neurons in Neurodegeneration discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

GABAergic Neurons in Neurodegeneration

GABAergic Neurons in Neurodegeneration

Overview

GABAergic Neurons in Neurodegeneration

Overview

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

PanglaoDB Marker Cross-References

External Database Links

Taxonomy & Classification

PanglaoDB Marker Cross-References

External Database Links

Introduction

Classification of GABAergic Neurons

Cortical and Hippocampal Interneurons

Perisomatic Inhibitors

Dendritic Inhibitors

Other Interneurons

Subcortical GABAergic Populations

Basal Ganglia

Thalamus

Other Regions

Molecular Mechanisms

GABA Synthesis and Release

Receptor Subtypes

GABA-A Receptors

GABA-B Receptors

Dysfunction in Neurodegenerative Diseases

Alzheimer's Disease

Changes Observed

Mechanisms

Therapeutic Implications

Parkinson's Disease

Basal Ganglia Alterations

Motor Symptoms

Treatment Effects

Huntington's Disease

Striatal Vulnerability

Pathophysiology

Amyotrophic Lateral Sclerosis

Therapeutic Approaches

Pharmacological Modulation

GABA-A Targeting Drugs

GABA-B Targeting

Novel Approaches

Emerging Strategies

Cell-Based Therapy

Gene Therapy

Biomarkers

Circuit Dysfunction in Neurodegeneration

Network Hyperexcitability Mechanisms

Oscillation Disruption

Specific Vulnerabilities

Parvalbumin (PV) Neurons

Somatostatin (SST) Neurons

Molecular Mechanisms of Vulnerability

Intrinsic Mechanisms

Synaptic Mechanisms

Receptor Alterations

Basal Ganglia Dysfunction in Movement Disorders

Parkinson's Disease

Huntington's Disease

Therapeutic Targeting

Amyotrophic Lateral Sclerosis

Cortical Hyperexcitability

Therapeutic Strategies[@menichetti2019]

Biomarkers and Diagnostics

Current Approaches

Emerging Biomarkers

Research Directions

Unresolved Questions

Future Directions

Key Publications

See Also

External Links

Pathway Diagram